Navigation Links
Covance Reports Fourth Quarter Pro Forma Net Revenue Of $561 Million, Pro Forma EPS Of $0.73 And Adjusted Net Orders Of $769 Million
Date:1/24/2013

nistrative358,854(30,460)(501)327,893  Depreciation and amortization117,708(3,470)(2,347)111,891  Goodwill impairment charge17,959(17,959)-Total costs and expenses2,249,882(33,930)(39,127)(18,028)-2,158,797Income from operations115,87733,93039,1279,274-198,208Other expense, net:  Interest expense, net3,5063,506  Foreign exchange transaction loss, net1,4741,474  Impairment of equity investment7,373(7,373)-  Gain on sale of investment(1,459)1,459-  Loss on sale of business169169Other expense, net11,063-(5,914)--5,149Income before taxes and equity investee earnings104,81433,93045,0419,274-193,059Taxes on income10,09910,7856,0092,74111,50141,135Equity investee earnings1717Net income $
94,732$
23,145$
39,032$
,533$
(11,501)$
51,941Basic earnings per share$
.73$
.42$
.71$
.12$
(0.21)$
2.77Weighted average shares outstanding - basic54,844,64154,844,64154,844,64154,844,64154,844,64154,844,641Diluted earnings per share$
.68$
.41$
.69$
.12$
(0.20)$
2.70Weighted average shares outstanding - diluted56,290,01056,290,01056,290,01056,290,01056,290,01056,290,010(1) Represents costs incurred to better align capacity to preclinical market demand and reduce overall cost structure.(2) Consists of inventory impairment and costs associated with the expected settlement of an inventory supply agreement ($21,168), goodwill impairment ($17,959), impairment of equity investment ($7,373) and a gain on the sale of an investment $1,459.(3) Represents results of operations at sites that were closed during the period.(4) Primarily represents favorable resolutions of income tax matters. COVANCE INC.GAAP to Pro Forma ReconciliationFor the year ended December 31, 2011(Dollars in thousands, except per share data)(UNAUDITED)AdjustmentsGAAP Restructuring Activities (1)Other
Charges (2)Income Tax Items (3)Pro FormaNet revenues$  2,095,938$  2,095,938R
'/>"/>
SOURCE Covance Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Covance To Present At The William Blair 32nd Annual Growth Stock Conference
2. Covance Reports Second Quarter Pro Forma Net Revenue Of $538 Million, Pro Forma EPS Of $0.65 And Adjusted Net Orders Of $701 Million
3. Covance to Present at the Morgan Stanley Global Healthcare Conference
4. Covance Reports Third Quarter Pro Forma Net Revenue Of $542 Million, Pro Forma EPS Of $0.72 And Adjusted Net Orders Of $701 Million
5. Covance To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
6. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
7. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
8. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
9. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
10. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
11. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)...  Lightlake Therapeutics Inc. ("Lightlake") (OTCQB: LLTP), a ... expertise in opioid antagonists, announced today that it ... with respect to its naloxone-based opioid overdose reversal ... has received an additional commitment from the National ... National Institutes of Health ("NIH"), to fund a ...
(Date:7/23/2014)... Calif. , July 23, 2014 This ... gather in Las Vegas for ... Spearheaded by educator, author, forward thinker and private practitioner ... bring experts together to candidly discuss clinical and practice ... day event is a unique opportunity to welcome fresh ...
(Date:7/23/2014)... Global healthcare company GSK reports Q2 results ... price competition and supply disruptions to its Consumer business. ... out that the company is very much in transition, citing ... about long-term prospects as well as the investments being ... Simon Dingemans adds that the company is reining ...
Breaking Medicine Technology:Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 2Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 32014 DOCtalk Registration Now Open 22014 DOCtalk Registration Now Open 3
(Date:7/24/2014)... Jose, California (PRWEB) July 24, 2014 ... Molecular diagnosis represents a rapidly expanding sector in ... probes, biochips, specimen collection devices, new detection technologies, ... high on sensitivity, versatility, and speed. In addition ... embraced for its benefits in patient stratification, drug ...
(Date:7/24/2014)... 24, 2014 Representatives from the internationally ... hand to provide educational and support resources at the ... week in Colorado Springs. , The Annual Meeting brings ... most renowned neurointerventional research centers in the ... together (with or at) symposiums, physician meetings, exhibit hall ...
(Date:7/24/2014)... 2014 “To care for him who shall ... orphan.” The inspired quote is attributed to Abraham Lincoln. It ... Affairs (VA). And yet the reality of Lincoln’s words, and ... for their service in times of conflict, leaves much to ... veterans locked in a battle they never expected to wage: ...
(Date:7/24/2014)... CA (PRWEB) July 24, 2014 The Republic ... unveil a new CARDAMOM CRÈME BRÛLÉE TEA to celebrate “The ... Spielberg, Oprah Winfrey and Juliet Blake. A hundred-foot journey begins ... and cross over into a new realm that is far ... however small in physical distance that materially changes the course ...
(Date:7/24/2014)... Crawford Technologies today announced the ... with AIIM, focusing on global trends in high-volume ... the survey indicated that even though organizations stated ... customer service, legal and regulatory compliance and historical ... exact facsimiles of these documents. , The survey ...
Breaking Medicine News(10 mins):Health News:Increasing Molecular Level Understanding of Disease State & Metabolism Drives the Molecular Diagnostics Market, According to New Report by Global Industry Analysts, Inc. 2Health News:Increasing Molecular Level Understanding of Disease State & Metabolism Drives the Molecular Diagnostics Market, According to New Report by Global Industry Analysts, Inc. 3Health News:Increasing Molecular Level Understanding of Disease State & Metabolism Drives the Molecular Diagnostics Market, According to New Report by Global Industry Analysts, Inc. 4Health News:Brain Aneurysm Foundation Provides Key Support to NeuroIntervential Physicians 2Health News:LawyersandSettlements.com Interviews Veterans Benefits Attorney Shanin Specter about Recent VA Hospital Reports 2Health News:LawyersandSettlements.com Interviews Veterans Benefits Attorney Shanin Specter about Recent VA Hospital Reports 3Health News:LawyersandSettlements.com Interviews Veterans Benefits Attorney Shanin Specter about Recent VA Hospital Reports 4Health News:LawyersandSettlements.com Interviews Veterans Benefits Attorney Shanin Specter about Recent VA Hospital Reports 5Health News:The Republic of Tea Unveils New Tea Inspired by “The Hundred-Foot Journey” 2Health News:The Republic of Tea Unveils New Tea Inspired by “The Hundred-Foot Journey” 3Health News:AIIM Research Shows 56% of Organizations Not Utilizing Digital Archiving Technology 2Health News:AIIM Research Shows 56% of Organizations Not Utilizing Digital Archiving Technology 3Health News:AIIM Research Shows 56% of Organizations Not Utilizing Digital Archiving Technology 4
... as "lazy eye," is a major cause of vision problems ... aged 20 to 70 in developed countries. In amblyopia the ... loses visual power as a result. When the condition is ... of children achieve 20/30 vision or better, the Amblyopia Treatment ...
... with rufinamide results in a significant reduction in seizure ... seizures (POS). Details of this study are now available ... Wiley-Blackwell on behalf of the International League Against Epilepsy. ... worldwide population according to the Centers for Disease Control ...
... study, derived from novel sleep research conducted by University of ... secret to a long life may come with just enough ... enough; eight hours is probably too much. A team ... of psychiatry at UC San Diego School of Medicine, revisited ...
... and MIT have reported a new way to biosynthesize ... an engineered strain of E. coli bacteria. ... to achieving cost-effective, large-scale production of Taxol and the ... work is reported in the October 1, 2010, issue ...
... neurologic disorders such as stroke, headache, Parkinson,s disease, epilepsy and ... journal Neurologic Clinics . Guest editor is Dr. ... University Chicago Stritch School of Medicine. "Great therapeutic strides ... decades," Biller wrote in the preface to the November 2010 ...
... MD, chief of Infectious Diseases at Nationwide Children,s Hospital, ... in a five-year, $3.4 million grant from the Eunice ... Development. Dr. Ramilo and a team of more than ... use of novel technologies for distinguishing between bacterial and ...
Cached Medicine News:Health News:Is photoscreening the best way to catch 'lazy eye'? 2Health News:Adjunctive rufinamide reduces refractory partial-onset seizures 2Health News:Women's study finds longevity means getting just enough sleep 2Health News:Researchers advance biosynthesis of potent anti-cancer drug Taxol 2Health News:NCH investigators receive grant to distinguish bacterial infections from viral infections in infants 2
Ballard trach care HMES and filters, tv 500, HME...
... Thermovent® T helps provide protection to the exposed ... and extremely lightweight making it ideal for active ... high rate of heat and moisture recovery, it ... ,All HMEs and filters have ISO standard tapered ...
For use with: , pulmonary function testing , nebulizer compressors , humidifiers , concentrators , proximal pressure lines ...
Indications For Usage: , ,For use during pulmonary lung function testing...
Medicine Products: